Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(1464/week)
Manufacturing
(748/week)
Energy
(572/week)
Technology
(1464/week)
Alternative Energy
(168/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Oncopeptides AB
May 29, 2020
Number of shares and votes in Oncopeptides
May 28, 2020
Oncopeptides Reinitiates Patient Enrollment to the Melflufen Clinical Program Following a Temporary Pause due to the COVID-19 Pandemic
May 26, 2020
Oncopeptides AB: Interim Report Q1 2020
May 22, 2020
Oncopeptides Completes Enrollment to the Pivotal Phase 3 Study OCEAN for Relapsed Refractory Multiple Myeloma - 450 Patients Included
May 14, 2020
Oncopeptides Announces New Clinical and Preclinical Melflufen Data at the Upcoming European Hematology Association Meeting
May 13, 2020
Oncopeptides Announces that Two Abstracts on Multiple Myeloma have been Accepted by the 2020 ASCO Annual Meeting
Apr 22, 2020
Annual General Meeting in Oncopeptides AB (publ)
Apr 02, 2020
Oncopeptides Strengthens its Corporate Communications Function by Appointing Rolf Gulliksen as Global Head of Corporate Communications
Mar 26, 2020
Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-class Refractory Multiple Myeloma Patients From the Pivotal HORIZON Study
Mar 23, 2020
The Lancet Haematology Publishes Results From Oncopeptides' Multicenter, International Phase 1/2 Study (O-12-M1)
Mar 20, 2020
Oncopeptides Provides Update Regarding COVID-19 Impact on the Melflufen Clinical Program
Mar 02, 2020
Oncopeptides Strengthens its Organization by Appointing Karolina Vilval as General Counsel
Jan 24, 2020
Oncopeptides will Host a Webcast on Monday, January 27th at 11.00 (CET)
Jan 07, 2020
Oncopeptides Strengthens its Regulatory Function by Appointing Karin Eklund Vanderpol as Head of Regulatory Affairs
Dec 17, 2019
Bulletin From the Extraordinary General Meeting in Oncopeptides AB (publ)
Dec 07, 2019
Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019
Dec 06, 2019
Oncopeptides Will Host a Webcast on Tuesday, December 10th at 13:00 (CET) to Provide an Update Regarding Data Presented at the ASH Annual Meeting
Dec 02, 2019
Oncopeptides Appoints Joseph Horvat as President North America
Nov 14, 2019
Extraordinary General Meeting in Oncopeptides AB (publ)
Nov 06, 2019
Oncopeptides to Highlight Data From Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019
‹‹
Page 2
››
Latest News
May 19, 2024
Orion Health awarded Panda Health Partner status for its Orchestral Health Intelligence Platform
May 19, 2024
Webblogic® Launches a Full Range of Products and Services for the Successful Manufacturing, Packaging &...
May 19, 2024
eWTP Arabia Capital's Technology Fund I Recognized as Top Performing VC Fund in the Preqin League Tables
May 19, 2024
France says will quell New Caledonia riots 'whatever the cost'
May 19, 2024
French forces smash roadblocks in bid to clear key New Caledonia road
May 19, 2024
France mounts 'major operation' to open route to New Caledonia's restive capital
May 19, 2024
French forces look to open route to New Caledonia's restive capital
May 18, 2024
Faraday Future Announces Fourth Quarter and Full Year 2023 Earnings Webcast Timing
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events